Muramyl dipeptide-mediated immunomodulation on monocyte subsets exerts therapeutic effects in a mouse model of Alzheimer’s disease

BACKGROUND: Muramyl dipeptide (MDP) is a component derived from minimal peptidoglycan motif from bacteria, and it is a ligand for the NOD2 receptor. Peripheral administration of MDP converts Ly6C(high) into Ly6C(low) monocytes. Previously, we have shown that Ly6C(low) monocytes play crucial roles in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neuroinflammation
Main Authors: Fani Maleki, Adham, Cisbani, Giulia, Plante, Marie-Michèle, Préfontaine, Paul, Laflamme, Nataly, Gosselin, Jean, Rivest, Serge
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7376735/
https://ncbi.nlm.nih.gov/pubmed/32698829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-020-01893-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados